ERα inhibition also eliminated the difference in Akt and ERK1/2 activation levels stimulated by Ob and Con sera exposure alone, suggesting that obesity-associated circulating factors are promoting greater nongenomic ERα activity. The gene discussed is AKT1; the disease is Obesity.